HEADER TRANSFERASE 05-DEC-12 4I9A TITLE CRYSTAL STRUCTURE OF SUS SCROFA QUINOLINATE PHOSPHORIBOSYLTRANSFERASE TITLE 2 IN COMPLEX WITH NICOTINATE MONONUCLEOTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: QUINOLINATE PHOSPHORIBOSYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.4.2.19; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SUS SCROFA; SOURCE 3 ORGANISM_COMMON: PIG; SOURCE 4 ORGANISM_TAXID: 9823; SOURCE 5 EXPRESSION_SYSTEM: SUS SCROFA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: PIG; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9823 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR H.-S.YOUN,M.-K.KIM,K.B.KANG,T.G.KIM,J.-G.LEE,J.Y.AN,K.R.PARK,Y.LEE, AUTHOR 2 J.Y.KANG,H.E.SONG,I.PARK,C.CHO,S.FUKUOKA,S.H.EOM REVDAT 3 08-NOV-23 4I9A 1 REMARK REVDAT 2 07-AUG-13 4I9A 1 JRNL REVDAT 1 01-MAY-13 4I9A 0 JRNL AUTH H.-S.YOUN,M.-K.KIM,G.B.KANG,T.G.KIM,J.-G.LEE,J.Y.AN, JRNL AUTH 2 K.R.PARK,Y.LEE,J.Y.KANG,H.E.SONG,I.PARK,C.CHO,S.FUKUOKA, JRNL AUTH 3 S.H.EOM JRNL TITL CRYSTAL STRUCTURE OF SUS SCROFA QUINOLINATE JRNL TITL 2 PHOSPHORIBOSYLTRANSFERASE IN COMPLEX WITH NICOTINATE JRNL TITL 3 MONONUCLEOTIDE JRNL REF PLOS ONE V. 8 62027 2013 JRNL REFN ESSN 1932-6203 JRNL PMID 23626766 JRNL DOI 10.1371/JOURNAL.PONE.0062027 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.1_1168) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.69 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 45199 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.217 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.920 REMARK 3 FREE R VALUE TEST SET COUNT : 2222 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.6904 - 5.2769 0.96 2745 135 0.2387 0.2428 REMARK 3 2 5.2769 - 4.1907 1.00 2737 142 0.2003 0.2416 REMARK 3 3 4.1907 - 3.6616 1.00 2714 159 0.1965 0.2419 REMARK 3 4 3.6616 - 3.3271 1.00 2704 134 0.2394 0.2989 REMARK 3 5 3.3271 - 3.0888 1.00 2685 159 0.2504 0.2889 REMARK 3 6 3.0888 - 2.9068 1.00 2678 133 0.2448 0.2892 REMARK 3 7 2.9068 - 2.7613 1.00 2698 129 0.2293 0.2982 REMARK 3 8 2.7613 - 2.6411 1.00 2682 148 0.2096 0.2804 REMARK 3 9 2.6411 - 2.5395 1.00 2699 124 0.2071 0.2534 REMARK 3 10 2.5395 - 2.4519 1.00 2684 149 0.1944 0.2477 REMARK 3 11 2.4519 - 2.3752 1.00 2687 113 0.1743 0.2325 REMARK 3 12 2.3752 - 2.3074 1.00 2679 132 0.1828 0.2309 REMARK 3 13 2.3074 - 2.2466 1.00 2609 162 0.1866 0.2629 REMARK 3 14 2.2466 - 2.1918 1.00 2696 121 0.1828 0.2335 REMARK 3 15 2.1918 - 2.1420 1.00 2700 133 0.1679 0.2238 REMARK 3 16 2.1420 - 2.0964 0.98 2580 149 0.1640 0.2194 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.050 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.19 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4336 REMARK 3 ANGLE : 1.351 5920 REMARK 3 CHIRALITY : 0.079 688 REMARK 3 PLANARITY : 0.008 772 REMARK 3 DIHEDRAL : 16.463 1542 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4I9A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-DEC-12. REMARK 100 THE DEPOSITION ID IS D_1000076465. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-FEB-04 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : BL-18B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45417 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.096 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 2JBM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 3 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z REMARK 290 6555 -X,-X+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 31040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 55410 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -165.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 59.55300 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 103.14882 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -59.55300 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 103.14882 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 424 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 31 77.33 -110.71 REMARK 500 HIS A 160 -152.64 62.84 REMARK 500 ASN A 193 -145.98 60.76 REMARK 500 ASN B 31 76.68 -110.69 REMARK 500 THR B 137 -166.05 -126.31 REMARK 500 HIS B 160 -155.41 70.22 REMARK 500 LEU B 164 3.25 -69.13 REMARK 500 ASN B 193 -121.25 59.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NCN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NCN B 301 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE PROTEIN WAS DIRECTLY PURIFIED FROM PORCINE KIDNEY. THE SEQUENCE REMARK 999 DATABASE REFERENCES FOR THIS PROTEIN DOES NOT CURRENTLY EXIST. DBREF 4I9A A 1 288 PDB 4I9A 4I9A 1 288 DBREF 4I9A B 1 288 PDB 4I9A 4I9A 1 288 SEQRES 1 A 288 MET ASP PRO GLU GLY LEU ALA LEU LEU LEU PRO PRO ALA SEQRES 2 A 288 THR LEU ALA THR LEU ALA ASP SER TRP LEU ARG GLU ASP SEQRES 3 A 288 CYS PRO GLY LEU ASN PRO VAL ALA LEU VAL THR GLY ALA SEQRES 4 A 288 ALA PRO SER GLN ALA VAL LEU TRP ALA LYS SER PRO GLY SEQRES 5 A 288 ILE LEU ALA GLY ARG PRO PHE PHE ASP ALA ILE PHE ALA SEQRES 6 A 288 GLN VAL ASN CYS GLN VAL SER TRP PHE LEU PRO GLU GLY SEQRES 7 A 288 SER LYS LEU VAL PRO VAL ALA LYS VAL ALA GLU VAL ARG SEQRES 8 A 288 GLY PRO ALA HIS CYS LEU LEU LEU GLY GLU ARG VAL ALA SEQRES 9 A 288 LEU ASN MET LEU ALA ARG CYS SER GLY VAL ALA SER ALA SEQRES 10 A 288 ALA ALA THR ALA VAL GLU THR ALA ARG GLY THR GLY TRP SEQRES 11 A 288 ALA GLY HIS VAL ALA GLY THR ARG LYS THR THR PRO GLY SEQRES 12 A 288 PHE ARG LEU VAL GLU LYS TYR GLY LEU LEU VAL GLY GLY SEQRES 13 A 288 ALA THR SER HIS ARG TYR ASP LEU GLY GLY LEU VAL MET SEQRES 14 A 288 VAL LYS ASP ASN HIS VAL VAL ALA ALA GLY GLY VAL LYS SEQRES 15 A 288 GLN ALA VAL GLN GLY ALA ARG ARG ALA ALA ASN PHE ALA SEQRES 16 A 288 LEU LYS VAL GLU VAL GLU CYS SER SER LEU GLN GLU ALA SEQRES 17 A 288 LEU GLU ALA ALA GLU ALA GLY ALA ASP LEU VAL LEU LEU SEQRES 18 A 288 ASP ASN PHE ARG PRO GLU GLU LEU HIS PRO THR ALA ALA SEQRES 19 A 288 ALA LEU LYS ALA GLN PHE PRO THR VAL GLY VAL GLU ALA SEQRES 20 A 288 SER GLY GLY VAL THR LEU ASP ASN LEU PRO GLN PHE CYS SEQRES 21 A 288 GLY PRO HIS ILE ASP VAL ILE SER LEU GLY MET LEU THR SEQRES 22 A 288 GLN ALA ALA PRO ALA LEU ASP PHE SER LEU LYS LEU PHE SEQRES 23 A 288 ALA GLU SEQRES 1 B 288 MET ASP PRO GLU GLY LEU ALA LEU LEU LEU PRO PRO ALA SEQRES 2 B 288 THR LEU ALA THR LEU ALA ASP SER TRP LEU ARG GLU ASP SEQRES 3 B 288 CYS PRO GLY LEU ASN PRO VAL ALA LEU VAL THR GLY ALA SEQRES 4 B 288 ALA PRO SER GLN ALA VAL LEU TRP ALA LYS SER PRO GLY SEQRES 5 B 288 ILE LEU ALA GLY ARG PRO PHE PHE ASP ALA ILE PHE ALA SEQRES 6 B 288 GLN VAL ASN CYS GLN VAL SER TRP PHE LEU PRO GLU GLY SEQRES 7 B 288 SER LYS LEU VAL PRO VAL ALA LYS VAL ALA GLU VAL ARG SEQRES 8 B 288 GLY PRO ALA HIS CYS LEU LEU LEU GLY GLU ARG VAL ALA SEQRES 9 B 288 LEU ASN MET LEU ALA ARG CYS SER GLY VAL ALA SER ALA SEQRES 10 B 288 ALA ALA THR ALA VAL GLU THR ALA ARG GLY THR GLY TRP SEQRES 11 B 288 ALA GLY HIS VAL ALA GLY THR ARG LYS THR THR PRO GLY SEQRES 12 B 288 PHE ARG LEU VAL GLU LYS TYR GLY LEU LEU VAL GLY GLY SEQRES 13 B 288 ALA THR SER HIS ARG TYR ASP LEU GLY GLY LEU VAL MET SEQRES 14 B 288 VAL LYS ASP ASN HIS VAL VAL ALA ALA GLY GLY VAL LYS SEQRES 15 B 288 GLN ALA VAL GLN GLY ALA ARG ARG ALA ALA ASN PHE ALA SEQRES 16 B 288 LEU LYS VAL GLU VAL GLU CYS SER SER LEU GLN GLU ALA SEQRES 17 B 288 LEU GLU ALA ALA GLU ALA GLY ALA ASP LEU VAL LEU LEU SEQRES 18 B 288 ASP ASN PHE ARG PRO GLU GLU LEU HIS PRO THR ALA ALA SEQRES 19 B 288 ALA LEU LYS ALA GLN PHE PRO THR VAL GLY VAL GLU ALA SEQRES 20 B 288 SER GLY GLY VAL THR LEU ASP ASN LEU PRO GLN PHE CYS SEQRES 21 B 288 GLY PRO HIS ILE ASP VAL ILE SER LEU GLY MET LEU THR SEQRES 22 B 288 GLN ALA ALA PRO ALA LEU ASP PHE SER LEU LYS LEU PHE SEQRES 23 B 288 ALA GLU HET NCN A 301 22 HET NCN B 301 22 HETNAM NCN NICOTINATE MONONUCLEOTIDE HETSYN NCN NAMN FORMUL 3 NCN 2(C11 H14 N O9 P) FORMUL 5 HOH *97(H2 O) HELIX 1 1 ASP A 2 LEU A 10 5 9 HELIX 2 2 PRO A 11 CYS A 27 1 17 HELIX 3 3 VAL A 33 GLY A 38 1 6 HELIX 4 4 GLY A 56 VAL A 67 1 12 HELIX 5 5 ALA A 94 THR A 128 1 35 HELIX 6 6 PHE A 144 GLY A 155 1 12 HELIX 7 7 LYS A 171 GLY A 179 1 9 HELIX 8 8 GLY A 180 ASN A 193 1 14 HELIX 9 9 SER A 204 GLY A 215 1 12 HELIX 10 10 ARG A 225 PHE A 240 1 16 HELIX 11 11 ASN A 255 CYS A 260 1 6 HELIX 12 12 GLY A 270 ALA A 275 1 6 HELIX 13 13 ASP B 2 LEU B 10 5 9 HELIX 14 14 PRO B 11 CYS B 27 1 17 HELIX 15 15 VAL B 33 GLY B 38 1 6 HELIX 16 16 GLY B 56 GLN B 66 1 11 HELIX 17 17 ALA B 94 THR B 128 1 35 HELIX 18 18 PHE B 144 GLY B 155 1 12 HELIX 19 19 LYS B 171 GLY B 179 1 9 HELIX 20 20 GLY B 180 ASN B 193 1 14 HELIX 21 21 SER B 204 ALA B 214 1 11 HELIX 22 22 ARG B 225 PHE B 240 1 16 HELIX 23 23 ASN B 255 CYS B 260 5 6 HELIX 24 24 GLY B 270 ALA B 275 1 6 SHEET 1 A 4 GLN A 70 TRP A 73 0 SHEET 2 A 4 ALA A 85 PRO A 93 -1 O GLU A 89 N SER A 72 SHEET 3 A 4 PRO A 41 ALA A 48 -1 N ALA A 44 O VAL A 90 SHEET 4 A 4 PHE A 281 LEU A 285 -1 O SER A 282 N TRP A 47 SHEET 1 B 2 GLY A 52 ILE A 53 0 SHEET 2 B 2 LYS A 80 LEU A 81 -1 O LEU A 81 N GLY A 52 SHEET 1 C 6 HIS A 133 ALA A 135 0 SHEET 2 C 6 VAL A 266 SER A 268 1 O ILE A 267 N ALA A 135 SHEET 3 C 6 GLY A 244 SER A 248 1 N ALA A 247 O VAL A 266 SHEET 4 C 6 LEU A 218 ASP A 222 1 N VAL A 219 O GLY A 244 SHEET 5 C 6 VAL A 198 CYS A 202 1 N CYS A 202 O LEU A 220 SHEET 6 C 6 VAL A 168 VAL A 170 1 N VAL A 170 O GLU A 199 SHEET 1 D 4 GLN B 70 TRP B 73 0 SHEET 2 D 4 ALA B 85 PRO B 93 -1 O ARG B 91 N GLN B 70 SHEET 3 D 4 PRO B 41 ALA B 48 -1 N LEU B 46 O VAL B 87 SHEET 4 D 4 PHE B 281 LEU B 285 -1 O LYS B 284 N VAL B 45 SHEET 1 E 2 GLY B 52 ILE B 53 0 SHEET 2 E 2 LYS B 80 LEU B 81 -1 O LEU B 81 N GLY B 52 SHEET 1 F 6 HIS B 133 ALA B 135 0 SHEET 2 F 6 VAL B 266 SER B 268 1 O ILE B 267 N ALA B 135 SHEET 3 F 6 GLY B 244 SER B 248 1 N ALA B 247 O VAL B 266 SHEET 4 F 6 LEU B 218 ASP B 222 1 N VAL B 219 O GLU B 246 SHEET 5 F 6 VAL B 198 CYS B 202 1 N CYS B 202 O LEU B 220 SHEET 6 F 6 VAL B 168 VAL B 170 1 N VAL B 170 O GLU B 201 CISPEP 1 PRO A 83 VAL A 84 0 -2.75 CISPEP 2 PRO B 83 VAL B 84 0 -7.61 SITE 1 AC1 14 ARG A 138 LYS A 139 HIS A 160 ARG A 161 SITE 2 AC1 14 LYS A 171 GLU A 201 ASP A 222 GLU A 246 SITE 3 AC1 14 SER A 248 GLY A 249 GLY A 250 SER A 268 SITE 4 AC1 14 LEU A 269 GLY A 270 SITE 1 AC2 11 ARG B 138 LYS B 139 HIS B 160 ARG B 161 SITE 2 AC2 11 LYS B 171 GLU B 201 ASP B 222 SER B 248 SITE 3 AC2 11 GLY B 249 LEU B 269 GLY B 270 CRYST1 119.106 119.106 93.737 90.00 90.00 120.00 P 3 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008396 0.004847 0.000000 0.00000 SCALE2 0.000000 0.009695 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010668 0.00000